Monographie - Acetazolamide - Stabilis 4.0

Son güncelleme :
19/11/2024

Diüretik

Acetazolamide

Enjeksiyon

Oral solüsyon / oral çözelti

Çözeltilerin stabilitesi

Karışımlardaki stabilitesi

Stabiliteyi etkileyen faktörler

Uyumluluk

Uygulama yöntemi

Kaynaklar

pdf

Kimyasal yapı

Ticari isim

Ticari isim

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Acetazolamide	Amerika Birleşik Devletleri, Kanada, Malezya
Diamox	Avustralya, Avusturya, Belçika, Büyük Britanya, Finlandiya, Fransa, Hollanda, İran, İrlanda, İsveç, İsviçre, Lüksemburg, Slovenya, Suudi Arabistan
Glaumox	yeni Zelanda

Kaynaklar

Enjeksiyon

Kaynaklar : Acetazolamide

	tip	yayın
198	Dergi	Gayed AA, Kheshary PR, Hinkle RL. Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection. Am J Health-Syst Pharm 1995 ; 52: 516-520.
316	Dergi	Veltri M, Lee CKK. Compatibility of neonatal parenteral nutrient solutions with selected intravenous drugs. Am J Health-Syst Pharm 1996 ; 53: 2611-2613.
460	Dergi	Parasrampuria J, Das Gupta V, Stewart KR. Stability of acetazolamide sodium in 5% dextrose and 0.9% sodium chloride injection. Am J Hosp Pharm 1987 ; 44: 358-360.
1201	Dergi	Yuhas EM, Lofton FT, Rosenberg HA, Mayron D, Baldinus JG. Cimetidine hydrochloride compatibility III: Room temperature stability in drug admixtures. Am J Hosp Pharm 1981 ; 38: 1919-1922.
2090	Dergi	Pere H, Chasse V, Forest JM, Hildgen P. Compatibility of injectable pantoprazole in Y-site administration. Pharmactuel 2004 ; 37: 193-196.
4389	Dergi	Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G. Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine. Pharmactuel 2019 ;52,4:206-213
4603	Dergi	Vallée M, Barthélémy I, Friciu M, Pelletier E, Forest J.M, Benoit F, Leclair G. Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration. Hosp Pharm 2021 ; 56, 4: 228-234.

Mentions Légales